iOnctura
iOnctura is a Geneve-based biotechnology company focused on immuno-oncology that develops selective cancer therapies.
4
Funding Rounds
$124.4m
Money raised
Funding
Funding series
Funding Series Analysis
The company iOnctura has raised a total of $124.4m in funding over 4 rounds.
Key Insights:
- iOnctura June 2024 Series B Funding Round: $86m
- iOnctura December 2022 Series B Funding Round: $16m
- iOnctura Series A round (extension), July 2020: $5.8m
- iOnctura Series A round, January 2020: $16.6m
iOnctura June 2024 Series B Funding Round
$86m
iOnctura December 2022 Series B Funding Round
$16m
iOnctura Series A round (extension), July 2020
$5.8m
iOnctura Series A round, January 2020
$16.6m
Industries
iOnctura is active in the following industries: